FDA wants to widen the Sentinel system search net for drug safety signals with its integration into the post-marketing surveillance system.
As part of the prescription drug user fee reauthorization, the agency also wants to explore new real-world safety data sources, including social media, as part of a wider effort to...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?